Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
about
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisEfficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literatureEffectiveness of insulin glargine in type 2 diabetes mellitus patients failing glycaemic control with premixed insulin: Adriatic countries data meta-analysis.Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analysesTherapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31)Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetesEfficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.Diabetes: glycaemic control in type 2 (drug treatments).Diabetes in the frail elderly: individualization of glycemic managementPractical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 DiabetesCombining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.Safety and effectiveness of biphasic insulin aspart 30 in different age-groups: a1chieve sub-analysis.Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?Intensification with prandial insulin.Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.Iatrogenic hypoglycemia in patients with type 2 diabetes: comparison of insulin analog premixes and human insulin premixes.Control of postprandial glucose levels with insulin in type 2 diabetes.Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.Humalog (lispro) for type 2 diabetes.Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.A UK analysis of the cost-effectiveness of Humalog Mix75/25 and Mix50/50 versus long-acting basal insulin.Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study.Taking the stress out of insulin initiation in type 2 diabetes mellitusSafety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen.Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study.A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis.
P2860
Q24656013-B4FC2025-0164-4B8A-9B21-3F8BD9B4B47AQ26749095-BC2F727F-08C8-418D-B718-5DA3D4C56ECBQ31082008-F768ECBB-87E2-4602-9537-AFEFC82BC7F3Q33585766-76A30023-072A-4BEB-9374-18DD54B8385DQ33879565-261200C3-8927-42A9-B6BC-BC4396B58D62Q34299641-D1C2FA96-1297-4902-8F88-01184A5F35AAQ34381425-06126916-0479-42FA-B904-4A8D487BF496Q34507342-7A74AF3D-8EA8-423A-B597-6B17DE2DE541Q34829290-90FEE7F0-C587-4370-B2F1-400879AE4074Q35961998-3259F3E6-46C4-4133-9DC4-382610621ED1Q36073434-5DC55FBA-0ACA-4999-BBF5-2C1DA1FC5E49Q37416127-119056EF-E223-4E5D-B7C6-1FFE1E4ACA75Q37468401-415F399A-F480-4C23-89E0-8E99D8AA69DFQ37558705-C788A04B-44A5-49A8-8D0D-CE74C1B212DAQ37577153-A39D2F93-773A-4536-8F9F-16AA58CE47B9Q37596578-72CB1966-50D4-4273-B176-EE51AFB322E5Q37600770-B3CADFB8-1392-4FAB-9B9B-678C8AA473CFQ37636162-73B94C7D-D467-4605-86FD-91C4A6A41852Q37885450-A01B0D4D-3C8B-46B4-A4BC-C4A11A660520Q37890773-9F175DFC-69D2-49B5-90D2-12C96F3AD010Q37890790-39C3A8E5-54DC-4020-9740-E0EE630FBD20Q37964744-535EB55F-B88E-44D5-B288-C236583ABE54Q38050151-19975257-0B7F-43BC-A872-19012C4E2045Q38317168-FB6AE3A5-E966-48D5-B58A-F84BED516FAAQ38980053-2D3D7CB6-CF16-47FB-9A72-00F0DD0ECDC6Q39514706-13A352D4-0179-471E-960C-C5C0DDF444DEQ40177955-93F9D5B1-D15C-47A8-B6E2-B4EC93E787CCQ41582284-44C849D1-1FC8-4A04-8542-04A04AF9FF58Q41867228-960003D2-C354-4DFB-AA91-05457F31135DQ43237621-8B1374B0-6218-458F-B2A8-98B94B3F28EBQ48320286-D7A8C8B4-022C-42CE-9038-B313151C26D9Q48432586-87398EC2-D390-4492-BEE2-8020231091E8Q50108204-334EAA64-6A7B-4F28-BB77-B08F500BBEA0Q51309415-16742DAF-6FCC-419E-BE77-F64F32799AE8Q52687570-910C8277-EB5E-4F0C-BDD8-F420C0A3D81D
P2860
Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Systematic review: comparative ...... analogues in type 2 diabetes.
@ast
Systematic review: comparative ...... analogues in type 2 diabetes.
@en
type
label
Systematic review: comparative ...... analogues in type 2 diabetes.
@ast
Systematic review: comparative ...... analogues in type 2 diabetes.
@en
prefLabel
Systematic review: comparative ...... analogues in type 2 diabetes.
@ast
Systematic review: comparative ...... analogues in type 2 diabetes.
@en
P2093
P2860
P1476
Systematic review: comparative ...... analogues in type 2 diabetes.
@en
P2093
Eric B Bass
Leonard Feldman
Lisa M Wilson
Muhammed Amer
Nisa Maruthur
Padmini Ranasinghe
Rehan Qayyum
Shari Bolen
Spyridon S Marinopoulos
P2860
P304
P356
10.7326/0003-4819-149-8-200810210-00242
P407
P577
2008-09-15T00:00:00Z